2015
DOI: 10.1016/j.molcel.2015.05.031
|View full text |Cite
|
Sign up to set email alerts
|

Small Molecule Inhibition of the Autophagy Kinase ULK1 and Identification of ULK1 Substrates

Abstract: Summary Many tumors become addicted to autophagy for survival, suggesting inhibition of autophagy as a potential broadly-applicable cancer therapy. ULK1/Atg1 is the only serine/threonine kinase in the core autophagy pathway and thus represents an excellent drug target. Despite recent advances in the understanding of ULK1 activation by nutrient deprivation, how ULK1 promotes autophagy remains poorly understood. Here, we screened degenerate peptide libraries to deduce the optimal ULK1 substrate motif and discove… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

28
630
2
5

Year Published

2016
2016
2023
2023

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 603 publications
(674 citation statements)
references
References 46 publications
28
630
2
5
Order By: Relevance
“…These targets include vps34, a class III PI3Kinase specific for autophagy, ULK1, the apical kinase for autophagy, and AMPK1, a kinase that activates ULK1. 34,35 However, because of the current lack of a small-molecule inhibitor of Atg7, we used RNA interference to suppress Atg7 and to illustrate proof of concept for this study. Our results show that Atg7 knockdown in AML cells results in a proapoptotic phenotype with increased chemosensitivity that translates to improved overall survival in vivo.…”
Section: Discussionmentioning
confidence: 99%
“…These targets include vps34, a class III PI3Kinase specific for autophagy, ULK1, the apical kinase for autophagy, and AMPK1, a kinase that activates ULK1. 34,35 However, because of the current lack of a small-molecule inhibitor of Atg7, we used RNA interference to suppress Atg7 and to illustrate proof of concept for this study. Our results show that Atg7 knockdown in AML cells results in a proapoptotic phenotype with increased chemosensitivity that translates to improved overall survival in vivo.…”
Section: Discussionmentioning
confidence: 99%
“…SBI-0206965 was recently identified as a selective small molecule inhibitor of ULK1 (51). Addition of the ULK1 inhibitor at a concentration used in the prior study (51) led to a decrease in IFN-␤ expression in WT MEFs treated with DMXAA. Thus, these data indicate that ULK1 is unlikely to be a negative regulator of STING-dependent signaling (Fig.…”
Section: The Ulk1 Inhibitor Sbi-0206965 Represses Activation Of Stingmentioning
confidence: 97%
“…Several groups have developed ATP-competitive inhibitors of ULK1 kinase (the apical kinase important for initiating autophagosome formation) that block autophagy in cells in vitro (Egan et al 2015;Lazarus and Shokat 2015;Petherick et al 2015). The most characterized of these started with a FAK inhibitor that potently inhibited ULK1 function (Russell et al 2013;Egan et al 2015).…”
Section: Ulk1mentioning
confidence: 99%